Correspondence
Cimetidine versus ranitidine in short term healing of duodenal ulcers SIR,-Quatrini et al (Giat 1984; 25: 1113-7) refer to the now familiar difficulty of statistically proving differences, other than large ones, in comparative trials of ulcer healing drugs. In the 12 published studies which compared cimetidine and ranitidine in short term healing of duodenal ulcers (full references available upon request) the differences between the healing rates on the two drugs reached statistical significance only once. ' In our own study,2 we observed a higher rate of healing in the ranitidine group compared with the cimetidine group, although this difference also did not reach statistical significance (Fisher's exact test; p=0.12). Because of the small number of patients in the study, it was possible that we were constructing a type 2 or error -that is, falsely accepting the null hypothesis. We therefore attempted to compare healing rates with cimetidine and ranitidine in all published trials in duodenal ulceration.
Of the 12 studies published, 10 reported higher healing rates in the ranitidine group. This is analogous to tossing a coin 12 times and getting 10 heads (or 10 tails); the probability of this happening, tested with the binomial distribution, is less than 0.05. We further analysed data only from those studies which were blinded, four week trials of cimetidine I g per day (as 200 mg tds, 400 mg nocte) versus ranitidine 300 mg per day (as 150 mg bd). Eight studies (1333 patients) fulfilled these criteria, and as far as we could ascertain from available data, they were comparable in design, mean age of patients, sex ratios, and percentages of smokers. This total number of patients approaches that calculated by Peterson Our study certainly does not exclude a difference between the two treatments in healing 'cimetidineresistant' ulcers; it simply suggests that if a difference exists it is not a large one. Furthermore, it confirms that a most important variable in the healing of these ulcers is the duration of treatment.2
To show a small difference is significant, a very large series is necessary; however, apart from the impossi-bility of recruiting so many patients the demonstration of such a small difference does not seem to us really important from the theoretical or clinical point of view. .2) The X2-test with Yates' correction for continuity2 was allegedly used to assess the difference in healing between the two groups, and this was claimed to be significant at the 2% level. Scrutiny of the data, however, suggests that this significance was achieved using the X -test (62 = 5 24, p<0*02 as in the text) and not the X-test with Yates' correction (X2 = 3 53, p>005). Fisher's test of exact probability for the data gives a p value of 0-0286 (one tail). As there is, a priori, no reason to suspect that TDB is necessarily better than cimetidine the two-tailed value of 0.057 applies, which is again not significant at conventional levels.
In view of these findings, and because 2x2 tables are so commonly used in gastroenterology to analyse the results of comparative ulcer healing studies, review 
